313 related articles for article (PubMed ID: 20625040)
21. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
23. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
24. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
Emami-Naeini P; Dohlman TH; Omoto M; Hattori T; Chen Y; Lee HS; Chauhan SK; Dana R
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1755-62. PubMed ID: 25091513
[TBL] [Abstract][Full Text] [Related]
25. Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.
Nakao S; Zandi S; Kohno R; Sun D; Nakama T; Ishikawa K; Yoshida S; Enaida H; Ishibashi T; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3830-6. PubMed ID: 23580489
[TBL] [Abstract][Full Text] [Related]
26. Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy.
Peebo BB; Fagerholm P; Traneus-Röckert C; Lagali N
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):830-5. PubMed ID: 19797212
[TBL] [Abstract][Full Text] [Related]
27. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic vessels identified in failed corneal transplants with neovascularisation.
Diamond MA; Chan SWS; Zhou X; Glinka Y; Girard E; Yucel Y; Gupta N
Br J Ophthalmol; 2019 Mar; 103(3):421-427. PubMed ID: 30348644
[TBL] [Abstract][Full Text] [Related]
29. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
30. Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.
Wong LL; Lee NG; Amarnani D; Choi CJ; Bielenberg DR; Freitag SK; D'Amore PA; Kim LA
Ophthalmology; 2016 Sep; 123(9):2028-36. PubMed ID: 27423310
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of Angiogenic Responses in Corneal Transplantation.
Inomata T; Mashaghi A; Di Zazzo A; Lee SM; Chiang H; Dana R
Cornea; 2017 Apr; 36(4):491-496. PubMed ID: 28060028
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
Lipp M; Bucher F; Parthasarathy A; Hos D; Onderka J; Cursiefen C; Bock F
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):943-9. PubMed ID: 24728466
[TBL] [Abstract][Full Text] [Related]
33. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
35. Regulation of blood vessel versus lymphatic vessel growth in the cornea.
Chung ES; Saban DR; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1613-8. PubMed ID: 19029028
[TBL] [Abstract][Full Text] [Related]
36. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease.
Lee HS; Hattori T; Park EY; Stevenson W; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5632-40. PubMed ID: 22789921
[TBL] [Abstract][Full Text] [Related]
37. Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.
Yuen D; Pytowski B; Chen L
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2593-7. PubMed ID: 21273538
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
[TBL] [Abstract][Full Text] [Related]
39. Hyperplasia, de novo lymphangiogenesis, and lymphatic regression in mice with tissue-specific, inducible overexpression of murine VEGF-D.
Lammoglia GM; Van Zandt CE; Galvan DX; Orozco JL; Dellinger MT; Rutkowski JM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H384-94. PubMed ID: 27342876
[TBL] [Abstract][Full Text] [Related]
40. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
Wuest TR; Carr DJ
J Exp Med; 2010 Jan; 207(1):101-15. PubMed ID: 20026662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
